Technology: An unprecedented incident involving an AI-based healthcare startup has sparked significant controversy within the medical community. The startup has launched a service that uses conversational AI to issue medical consultations and prescriptions – a practice that has been strongly condemned for violating existing medical laws.
Users visiting the startup’s website can receive a virtual consultation where the AI inquires about symptoms, their onset, frequency, and aggravating factors. After a series of questions, the AI suggests potential diagnoses. Once a diagnosis is selected by the user, a prescription is automatically generated. Worryingly, this process bypasses the need for a licensed physician to write and issue a prescription, raising legal challenges.
Journalistic investigations have revealed a shocking misuse of medical institution data. Prescriptions were fraudulently issued in the names of real medical clinics and doctors, none of whom knew or had an agreement with the AI service provider. Additionally, the prescriptions lacked proper user identification steps, a serious flaw that raises major concerns about patient safety and data protection.
Medical associations have filed formal complaints against the company, condemning unlicensed medical acts and unauthorized use of personal data. These actions risk inappropriate drug use and potential harm to patients. Despite the startup’s claims of only assisting doctors, the medical community insists that such AI-mediated prescriptions are both unlawful and dangerous.
With its practices under intense scrutiny, the startup faced opposition from legal authorities and pharmaceutical associations alike, highlighting the urgent need for stringent regulations in AI-powered healthcare innovations. As the controversy unfolds, the future of AI in medical applications hangs in the balance, pending legal review and potential reforms.
